(Q54711237)

3 June 2018

title

Depressed expression of Klotho and FGF receptor 1 in hyperplastic parathyroid glands from uremic patients. (English)

1 reference

3 June 2018

0 references

1

1 reference

3 June 2018

author name string

Shunsuke Goto

2

1 reference

3 June 2018

Hideki Fujii

3

1 reference

3 June 2018

Yasuhiro Hamada

4

1 reference

3 June 2018

Akira Kobayashi

5

1 reference

3 June 2018

Koji Shibuya

6

1 reference

3 June 2018

Yoshihiro Tominaga

7

1 reference

3 June 2018

Naoki Otsuki

8

1 reference

3 June 2018

Ken-Ichi Nibu

9

1 reference

3 June 2018

Kimie Nakagawa

10

1 reference

3 June 2018

Naoko Tsugawa

11

1 reference

3 June 2018

Toshio Okano

12

1 reference

3 June 2018

Riko Kitazawa

13

1 reference

3 June 2018

Masafumi Fukagawa

14

1 reference

3 June 2018

Tomoyuki Kita

15

1 reference

3 June 2018

language of work or name

English

0 references

publication date

4 November 2009

1 reference

3 June 2018

published in

Kidney International

1 reference

3 June 2018

volume

77

1 reference

3 June 2018

issue

3

1 reference

3 June 2018

page(s)

232-238

1 reference

3 June 2018

https://scigraph.springernature.com/pub.10.1038/ki.2009.414

exact match

0 references

cites work

Mechanisms of secondary hyperparathyroidism

1 reference

https://api.crossref.org/works/10.1038%2FKI.2009.414

7 January 2021

Basic and clinical aspects of parathyroid hyperplasia in chronic kidney disease.

1 reference

https://api.crossref.org/works/10.1038%2FKI.2009.414

7 January 2021

Circulating concentration of FGF-23 increases as renal function declines in patients with chronic kidney disease, but does not change in response to variation in phosphate intake in healthy volunteers

1 reference

https://api.crossref.org/works/10.1038%2FKI.2009.414

7 January 2021

Possible involvement of circulating fibroblast growth factor 23 in the development of secondary hyperparathyroidism associated with renal insufficiency.

1 reference

https://api.crossref.org/works/10.1038%2FKI.2009.414

7 January 2021

Fibroblast growth factor-23 mitigates hyperphosphatemia but accentuates calcitriol deficiency in chronic kidney disease

1 reference

https://api.crossref.org/works/10.1038%2FKI.2009.414

7 January 2021

Pathogenic role of Fgf23 in Hyp mice.

1 reference

https://api.crossref.org/works/10.1038%2FKI.2009.414

7 January 2021

Klotho converts canonical FGF receptor into a specific receptor for FGF23

1 reference

https://api.crossref.org/works/10.1038%2FKI.2009.414

7 January 2021

Regulation of fibroblast growth factor-23 signaling by klotho

1 reference

https://api.crossref.org/works/10.1038%2FKI.2009.414

7 January 2021

FGFR3 and FGFR4 do not mediate renal effects of FGF23.

1 reference

https://api.crossref.org/works/10.1038%2FKI.2009.414

7 January 2021

FGF-23 is a potent regulator of vitamin D metabolism and phosphate homeostasis

1 reference

https://api.crossref.org/works/10.1038%2FKI.2009.414

7 January 2021

Fibroblast growth factor 23 impairs phosphorus and vitamin D metabolism in vivo and suppresses 25-hydroxyvitamin D-1alpha-hydroxylase expression in vitro

1 reference

https://api.crossref.org/works/10.1038%2FKI.2009.414

7 January 2021

Intravenous calcitriol therapy increases serum concentrations of fibroblast growth factor-23 in dialysis patients with secondary hyperparathyroidism

1 reference

https://api.crossref.org/works/10.1038%2FKI.2009.414

7 January 2021

Serum fibroblast growth factor-23 levels predict the future refractory hyperparathyroidism in dialysis patients.

1 reference

https://api.crossref.org/works/10.1038%2FKI.2009.414

7 January 2021

Pretreatment serum FGF-23 levels predict the efficacy of calcitriol therapy in dialysis patients.

1 reference

https://api.crossref.org/works/10.1038%2FKI.2009.414

7 January 2021

Fibroblast growth factor-23 regulates parathyroid hormone and 1alpha-hydroxylase expression in cultured bovine parathyroid cells

1 reference

https://api.crossref.org/works/10.1038%2FKI.2009.414

7 January 2021

Decreased 1,25-dihydroxyvitamin D3 receptor density is associated with a more severe form of parathyroid hyperplasia in chronic uremic patients.

1 reference

https://api.crossref.org/works/10.1038%2FKI.2009.414

7 January 2021

Depressed expression of calcium receptor in parathyroid gland tissue of patients with hyperparathyroidism.

1 reference

https://api.crossref.org/works/10.1038%2FKI.2009.414

7 January 2021

Association of decreased calcium-sensing receptor expression with proliferation of parathyroid cells in secondary hyperparathyroidism

1 reference

https://api.crossref.org/works/10.1038%2FKI.2009.414

7 January 2021

Reduced p21, p27 and vitamin D receptor in the nodular hyperplasia in patients with advanced secondary hyperparathyroidism

1 reference

https://api.crossref.org/works/10.1038%2FKI.2009.414

7 January 2021

Histopathology, pathophysiology, and indications for surgical treatment of renal hyperparathyroidism

1 reference

https://api.crossref.org/works/10.1038%2FKI.2009.414

7 January 2021

Endocrine functions of bone in mineral metabolism regulation.

1 reference

https://api.crossref.org/works/10.1038%2FKI.2009.414

7 January 2021

Type I membrane klotho expression is decreased and inversely correlated to serum calcium in primary hyperparathyroidism

1 reference

https://api.crossref.org/works/10.1038%2FKI.2009.414

7 January 2021

alpha-Klotho as a regulator of calcium homeostasis

1 reference

https://api.crossref.org/works/10.1038%2FKI.2009.414

7 January 2021

Severely reduced production of klotho in human chronic renal failure kidney.

1 reference

https://api.crossref.org/works/10.1038%2FKI.2009.414

7 January 2021

Klotho protein activates the PKC pathway in the kidney and testis and suppresses 25-hydroxyvitamin D3 1alpha-hydroxylase gene expression.

1 reference

https://api.crossref.org/works/10.1038%2FKI.2009.414

7 January 2021

The progression of aging in klotho mutant mice can be modified by dietary phosphorus and zinc

1 reference

https://api.crossref.org/works/10.1038%2FKI.2009.414

7 January 2021

Parathyroid growth and regression in experimental uremia

1 reference

https://api.crossref.org/works/10.1038%2FKI.2009.414

7 January 2021

EGFR activation increases parathyroid hyperplasia and calcitriol resistance in kidney disease

1 reference

https://api.crossref.org/works/10.1038%2FKI.2009.414

7 January 2021

Parathyroid hyperplasia in uremic rats precedes down-regulation of the calcium receptor.

1 reference

https://api.crossref.org/works/10.1038%2FKI.2009.414

7 January 2021

Phosphorus restriction prevents parathyroid gland growth. High phosphorus directly stimulates PTH secretion in vitro

1 reference

https://api.crossref.org/works/10.1038%2FKI.2009.414

7 January 2021

The calcimimetic compound NPS R-568 suppresses parathyroid cell proliferation in rats with renal insufficiency. Control of parathyroid cell growth via a calcium receptor

1 reference

https://api.crossref.org/works/10.1038%2FKI.2009.414

7 January 2021

Clinical practice guideline for the management of secondary hyperparathyroidism in chronic dialysis patients

1 reference

https://api.crossref.org/works/10.1038%2FKI.2009.414

7 January 2021

Identifiers

DOI

10.1038/KI.2009.414

1 reference

3 June 2018

1 reference

3 June 2018